The European Medicines Agency (EMA) said on Friday that a decision to authorise the use of the AstraZeneca/Oxford coronavirus vaccine could be made by the end of the month, with the bloc being under pressure to speed out the vaccines rollout.
“Possible conclusion – end of Jan, depending on data and evaluation progress,” the Amsterdam-based agency wrote in a Twitter post.
After having received more data from the company, EMA is expecting Astra Zeneca to submit a conditional marketing application for its #COVID19vaccine next week. Possible conclusion – end of Jan, depending on data and evaluation progress. #EMAPublicMeeting2
— EU Medicines Agency (@EMA_News) January 8, 2021
EMA said it was expecting AstraZeneca to submit a con…
This story is part of New Europe’s Premium content.
| To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑ |
